Cargando…

Aptamer-functionalized Hybrid Nanoparticles to Enhance the Delivery of Doxorubicin into Breast Cancer Cells by Silencing P-glycoprotein

OBJECTIVE: The MDR of metastatic breast cancer cells is accompanied by the overexpression of P-gp transporter. This study has been focused to determine whether silencing the expression of P-gp by aptamer-labeled siRNA nanoparticles could enhance the delivery of doxorubicin into breast cancer cells i...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chandra, Sruti, Michael Nguyen, Hoang, Wiltz, Kylar, Hall, Nicholas, Chaudhry, Shanzay, Olverson, George, Mandal, Tarun, Dash, Srikanta, Kundu, Anup
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213597/ https://www.ncbi.nlm.nih.gov/pubmed/32395707 http://dx.doi.org/10.29245/2578-2967/2020/1.1176

Ejemplares similares

Novel siRNA formulation to effectively knockdown mutant p53 in osteosarcoma
por: Kundu, Anup K., et al.
Publicado: (2017)

EpCAM Aptamer-mediated Survivin Silencing Sensitized Cancer Stem Cells to Doxorubicin in a Breast Cancer Model
por: Wang, Tao, et al.
Publicado: (2015)

Aptamer-Aptamer Chimera for Targeted Delivery and ATP-Responsive Release of Doxorubicin into Cancer Cells
por: Esawi, Ezaldeen, et al.
Publicado: (2021)

Operation Diversify Plastic Surgery: An Innovative Strategy to Increase Diversity in Plastic and Reconstructive Surgery
por: Downer, Mauricio A., et al.
Publicado: (2023)

Novel Nanosomes for Gene Delivery to Plasmodium falciparum-infected Red Blood Cells
por: Gopalakrishnan, Anusha M., et al.
Publicado: (2013)

Aptamer–drug conjugate: targeted delivery of doxorubicin in a HER3 aptamer-functionalized liposomal delivery system reduces cardiotoxicity
por: Dou, Xiao-qian, et al.
Publicado: (2018)

Targeted delivery of doxorubicin and therapeutic FOXM1 aptamer to tumor cells using gold nanoparticles modified with AS1411 and ATP aptamers
por: Abdollahzade, Aref, et al.
Publicado: (2023)

Targeted Therapy of Colon Cancer by Aptamer-Guided Holliday Junctions Loaded with Doxorubicin
por: Yao, Fengjiao, et al.
Publicado: (2020)

Anti-Proliferative Effect of Doxorubicin-Loaded AS1411 Aptamer on Colorectal Cancer Cell
por: Lohlamoh, Walaiporn, et al.
Publicado: (2021)

Pleiotrophin promotes chemoresistance to doxorubicin in osteosarcoma by upregulating P-glycoprotein
por: Wu, Dapeng, et al.
Publicado: (2017)

Graphene-based hybrid nanoparticle of doxorubicin for cancer chemotherapy
por: SreeHarsha, Nagaraja, et al.
Publicado: (2019)

DNA aptamer selection for SARS-CoV-2 spike glycoprotein detection
por: Martínez-Roque, Mateo Alejandro, et al.
Publicado: (2022)

Aptamers in the Therapeutics and Diagnostics Pipelines
por: Kaur, Harleen, et al.
Publicado: (2018)

Target-specific delivery of doxorubicin to retinoblastoma using epithelial cell adhesion molecule aptamer
por: Subramanian, Nithya, et al.
Publicado: (2012)

Selection of a novel CD19 aptamer for targeted delivery of doxorubicin to lymphoma cells
por: Hu, Yan, et al.
Publicado: (2018)

Identification of Aptamer-Binding Sites in Hepatitis C Virus Envelope Glycoprotein E2
por: Chen, Fan, et al.
Publicado: (2015)

Aptamers based sensing of pregnancy associated glycoproteins (PAG) of bovine for early pregnancy detection
por: Yadav, Munna Lal, et al.
Publicado: (2021)

Aptamer Laden Liquid Crystals Biosensing Platform for the Detection of HIV-1 Glycoprotein-120
por: Abbasi, Amna Didar, et al.
Publicado: (2021)

Aptamer‐targeted DNA nanostructures with doxorubicin to treat protein tyrosine kinase 7‐positive tumours
por: Liu, Mengting, et al.
Publicado: (2018)

STAT3 Gene Silencing by Aptamer-siRNA Chimera as Selective Therapeutic for Glioblastoma
por: Esposito, Carla Lucia, et al.
Publicado: (2017)

Hybrid Antibody–Aptamer Assay for Detection of Tetrodotoxin in Pufferfish
por: Shkembi, Xhensila, et al.
Publicado: (2021)

The influence of P-glycoprotein expression and its inhibitors on the distribution of doxorubicin in breast tumors
por: Patel, Krupa J, et al.
Publicado: (2009)

Effects of Phytochemical P-Glycoprotein Modulators on the Pharmacokinetics and Tissue Distribution of Doxorubicin in Mice
por: Kim, Tae Hwan, et al.
Publicado: (2018)

Ganglion Cyst of Knee from Hoffa’s Fat Pad Protruding Anterolaterally Through Retinacular Rent: A Case Report
por: Saha, Partha, et al.
Publicado: (2015)

Interferon and Ribavirin Combination Treatment Synergistically Inhibit HCV Internal Ribosome Entry Site Mediated Translation at the Level of Polyribosome Formation
por: Panigrahi, Rajesh, et al.
Publicado: (2013)

Aptamer-Mediated Codelivery of Doxorubicin and NF-κB Decoy Enhances Chemosensitivity of Pancreatic Tumor Cells
por: Porciani, David, et al.
Publicado: (2015)

Transforming doxorubicin into a cancer stem cell killer via EpCAM aptamer-mediated delivery
por: Xiang, Dongxi, et al.
Publicado: (2017)

Doxorubicin Loaded DNA Aptamer Linked Myristilated Chitosan Nanogel for Targeted Drug Delivery to Prostate Cancer
por: Atabi, Fereshteh, et al.
Publicado: (2017)

Aptamer Functionalized Upconversion Nanotheranostic Agent With Nuclear Targeting as the Highly Localized Drug-Delivery System of Doxorubicin
por: Song, Xinyue, et al.
Publicado: (2021)

PrP(C) Aptamer Conjugated–Gold Nanoparticles for Targeted Delivery of Doxorubicin to Colorectal Cancer Cells
por: Go, Gyeongyun, et al.
Publicado: (2021)

miR-451 Silencing Inhibited Doxorubicin Exposure-Induced Cardiotoxicity in Mice
por: Li, Jun, et al.
Publicado: (2019)

Relationship between therapeutic efficacy of doxorubicin-transferrin conjugate and expression of P-glycoprotein in chronic erythromyeloblastoid leukemia cells sensitive and resistant to doxorubicin
por: Szwed, Marzena, et al.
Publicado: (2014)

Commentary: “Aptamer-functionalized hybrid nanoparticle for the treatment of breast cancer”
por: Evans, Ronise
Publicado: (2017)

Comparison of (99m)Tc-sestamibi and doxorubicin to monitor inhibition of P-glycoprotein function
por: Muzzammil, T, et al.
Publicado: (2001)

Early multidrug resistance, defined by changes in intracellular doxorubicin distribution, independent of P-glycoprotein.
por: Schuurhuis, G. J., et al.
Publicado: (1991)

Aptamer–Gold(III) Complex Nanoparticles: A New Way to Detect Cu, Zn SOD Glycoprotein
por: Dekhili, Rawdha, et al.
Publicado: (2020)

Single-dose of BBV-152 and AZD1222 increases antibodies against spike glycoprotein among healthcare workers recovered from SARS-CoV-2 infection
por: Parai, Debaprasad, et al.
Publicado: (2021)

Turnover of Variant Surface Glycoprotein in Trypanosoma brucei Is Not Altered in Response to Specific Silencing
por: Sharif, Mohamed, et al.
Publicado: (2022)

ssDNA Aptamer Specifically Targets and Selectively Delivers Cytotoxic Drug Doxorubicin to HepG2 Cells
por: Yu, Ge, et al.
Publicado: (2016)

Mucin-1 aptamer-armed superparamagnetic iron oxide nanoparticles for targeted delivery of doxorubicin to breast cancer cells
por: Aghanejad, Ayuob, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_1jll34o5fa736ki0dlp9b3j40i